Medicine is a high-tech, high-risk, high-input and high-return industry, which has always been the focus of competition in developed countries. With the development of economic globalization, international competition is becoming increasingly fierce. In order to enhance international competitiveness, multinational companies have established a global production and sales network and expanded their market share through large-scale mergers and acquisitions and international capital market operations.
Due to the rapid development of modern biotechnology, it has had a revolutionary impact on the pharmaceutical industry. With the deepening of understanding of difficult diseases and the advent of many new biotechnological drugs, the transformation of traditional industries with biotechnology will greatly change the face of the pharmaceutical industry. Developed countries in the world use capital, technology and market advantages to implement monopoly, and traditional Chinese medicine has launched a new round of competition with developed countries in the field of biotechnology.
Extended data:
From 2065438 to 2008, the General Office of the State Council issued the Opinions on Reforming and Perfecting the Policy of Supply Guarantee and Use of Generic Drugs, which promoted the research and development of generic drugs in an all-round way and improved the quality and efficacy by improving supporting policies.
The relevant person in charge of the National Health and Wellness Committee said: "The Opinions on Reforming and Improving the Policy of Supply Guarantee and Use of Generic Drugs proposes to study and improve the drug intellectual property protection system that is compatible with China's economic and social development level and industrial development stage in accordance with the principle of encouraging the creation of new drugs and encouraging the research and development of generic drugs.
Strengthening the protection of drug intellectual property rights and encouraging the creation of new drugs are the needs of building an innovative country and promoting the innovative development of China's pharmaceutical industry. At the same time, the monopoly brought by the excessive protection of drug intellectual property rights will inevitably raise the price of drugs and reduce the accessibility of drugs.
Therefore, according to the principle of encouraging both the creation of new drugs and the research and development of generic drugs, China should further study and improve the drug intellectual property protection system suitable for China's economic and social development level and industrial development stage, strive to build a scientific and systematic drug intellectual property protection mechanism, balance the right to health and drug intellectual property, and safeguard the health rights and interests of the broad masses of the people.
The opinion also clearly pointed out that compulsory licensing of drug patents should be implemented according to law to protect public health in the event of public health emergencies such as serious infectious diseases in the country. "
Baidu encyclopedia-medicine industry
People's Network-from a big pharmaceutical country to a powerful pharmaceutical country; Interpreting the New Deal of Generic Drug Management: Four Highlights